{"": [81, 1099, 0], "Introduction": [1100, 9448, 0], "Selection against a chemically cross-linked SARS-CoV-2 Mpro homodimer": [9473, 13761, 0], "Synthesis and in vitro evaluation of cyclic peptide inhibitors of SARS-CoV-2 Mpro": [13762, 16139, 0], "Probing the binding interaction of lead cyclic peptide 1": [16140, 21541, 0], "Co-crystallization of peptide 1 and a selenoether analogue with SARS-CoV-2 Mpro": [21542, 27477, 0], "Antiviral activity of cyclic peptide SARS-CoV-2 Mpro inhibitors": [27478, 31043, 0], "Results and discussion": [9449, 31043, 1], "Conclusions": [31044, 34459, 0], "Data availability": [34460, 34850, 0], "Author contributions": [34851, 35563, 0], "Conflicts of interest": [35564, 35622, 0], "Supplementary Material": [35623, 35650, 0]}